Lupin bags USFDA approval for Multiple myeloma treatment Ruchika Sharma17 Sept 2025 6:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...
Lupin gets 6 USFDA observations for Nagpur facility Ruchika Sharma17 Sept 2025 11:00 AM ISTMumbai: Lupin has announced that the U.S. Food and Drugs Administration (USFDA) has closed the inspection with six observations at the company's...
Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, Brazil Ruchika Sharma15 Sept 2025 5:13 PM ISTLupin Manufacturing Solutions has announced that Empagliflozin API, manufactured at its Vizag facility, has received CADIFA approval from ANVISA,...
Lupin gets 2 USFDA observations for Aurangabad facility Ruchika Sharma6 Sept 2025 11:21 AM ISTMumbai: Lupin has received two observations from the U.S. Food and Drug Administration (USFDA) at the closure of an inspection at the Company's...
Lupin wins USFDA nod for Risperidone for extended-release injectable suspension for schizophrenia Ruchika Sharma3 Sept 2025 2:30 PM ISTThis is Lupin's first product using proprietary Nanomi B.V.'s technology and has a 180-day CGT exclusivity.
Lupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made Mandatory Susmita Roy1 Sept 2025 4:23 PM ISTNew Delhi: Lupin has got approval from the Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), to conduct a...
Lincoln Pharma appoints Raja Karunanidhi Nagarajan as Senior General Manager-RnD Ruchika Sharma30 Aug 2025 11:30 AM ISTAhmedabad: Lincoln Pharma has announced the appointment of Raja Karunanidhi Nagarajan as Senior General Manager- Research & Development...
Lupin, Natco Launch Bosentan Tablets in US With 180-Day Exclusivity Parthika Patel20 Aug 2025 2:38 PM ISTMumbai: Global pharma major Lupin Limited on Wednesday announced the launch of Bosentan Tablets for Oral Suspension, 32 mg in the United States, with...
Lupin to Conduct BE Study for Synthetic Semaglutide Tablets in 3 Strengths Parthika Patel15 Aug 2025 3:02 PM ISTNew Delhi: Lupin Limited has received the green light from the Subject Expert Committee (SEC) under the Endocrinology & Metabolism division of the...
Lupin partners with Sandoz to market, commercialize Ranibizumab biosimilar across multiple regions Ruchika Sharma12 Aug 2025 5:21 PM ISTLupin will be responsible for manufacturing the product and for regulatory submissions.
Lupin unveils Glucagon for Injection for severe hypoglycemia in patients with diabetes mellitus in US Ruchika Sharma11 Aug 2025 12:44 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Glucagon for Injection USP, 1mg/vial packaged in an emergency kit in the...
Lupin, Sun Pharma and 1 other recall products in US Ruchika Sharma28 July 2025 2:45 PM ISTNew Delhi: Leading pharmaceutical companies, Sun Pharma, Dr Reddy's Laboratories and Lupin are recalling products from the US market...
